Stock Comparison

BMRN vs REGN

Biomarin Pharmaceutical Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

BMRN

Biomarin Pharmaceutical Inc

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$11.40B

$66.35B

P/E (TTM)

42.5

15.5

Forward P/E

11.9

14.1

Price/Sales

3.5

4.5

Price/Book

1.8

2.1

EV/EBITDA

22.0

10.5

Dividend Yield

—

0.58%

Profitability

Net Margin

8.29%

29.60%

Operating Margin

18.00%

20.70%

Return on Equity

4.48%

14.50%

Return on Assets

4.49%

6.13%

Growth (YoY)

Revenue Growth

2.80%

19.00%

Earnings Growth

-43.10%

-7.20%

Price & Risk

Beta

0.2

52-Week High

$66.28

$818.90

52-Week Low

$49.26

$516.07

Analyst Target

$87.85

$833.31

Compare BMRN and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.